Salbutamol

Salbutamol Dragon Pharma

Salbutamol, also known as albuterol, is a short-acting beta-2 adrenergic agonist medication that belongs to the sympathomimetic family. It is commonly used in the treatment of conditions characterized by bronchoconstriction, such as asthma and chronic obstructive pulmonary disease (COPD). The primary mechanism of action involves the stimulation of beta-2 receptors on the smooth muscles surrounding the airways, leading to bronchodilation and an increase in airflow to the lungs. This is achieved by relaxing these muscles and reducing the resistance in the airways, thereby alleviating symptoms such as wheezing, coughing, and shortness of breath. Salbutamol can be administered via various routes, including inhalation through a metered-dose inhaler or nebulizer, orally, or intravenously. It is a first-line treatment for acute asthma exacerbations and is also used as a preventive measure prior to exercise or exposure to known asthma triggers.

References

The efficacy and safety profile of salbutamol are well-documented in numerous medical textbooks and research studies, such as the British National Formulary and the Global Initiative for Asthma guidelines, which are widely recognized for providing evidence-based recommendations for the management of respiratory disorders.